3EA91A1605BE66BB87258832007D86A2 Hearing Summary

Senators Cooke and Pettersen, co-prime sponors, returned to the committee for consideration of amendments on House Bill 22-1326, concerning fentanyl accountability and prevention.  The bill was first heard in Senate Judiciary on April 26, 2022. 

Senator Cooke distributed and explained Amendment L.163 about a social media study (Attachment A). 

Committee members asked questions about the study. 

Senator Pettersen distributed and explained Amendment L.164 regarding pharmacies (Attachment B). 

Senator Pettersen distributed and explained Amendment L.165 which includes clean-up language regarding Food and Drug Administration approval (Attachment C). 

Senator Pettersen distributed and explained Amendment L.170 that updates certain language in the bill for consistency (Attachment D). 

Senator Cooke distributed and explained Amendment L.178 that allows for the addition of potential other potent drugs (Attachment E). 

Senator Cooke distributed and explained Amendment L.187 about carfentanal (Attachment F). 

Senator Cooke distributed and explained Amendment L.188 about opiod or opiate terminology (Attachment G). 

Senator Cooke subsequently withdrew the amendment.

Senator Pettersen distributed and explained Amendment L. 189 which concerns duplicate language in addition to studies about fentanyl (Attachment H).

Jacob Baus, Office of Legislative Legal Services, discussed the amendment in greater detail. 

Committee members asked questions about the studies, as oulined in the amendment. 

Senator Pettersen distributed and explained Amendment L.190 about community corrections and medical detox providers (Attachment I).

Senator Pettersen distributed and explained Amendment L.192 regarding a post-enactment review  (Attachment J ). 

Senator Pettersen distributed and explained Amendment L.193 regarding an overdose prevention review committee (Attachment K).

Committee members asked questions about the necessity of a review committee. 

Senator Rodriguez withdrew the motion for this amendment. 

Senator Pettersen distributed and explained Amendment L.195 to update language for consistency (Attachment L).

Senator Pettersen distributed and explained Amendment L.196 regarding medically assisted treatment in the jails (Attachment M). 

A conceptual amendment to L.196 was suggested to delete lines 13 and 14.  .

Senator Cooke distributed and explained Amendment L. 197 about law enforcement investigations of overdoses (Attachment N).

Senator Cooke distributed and explained Amendment  L.198 about a mapping application (Attachment O).  

Committee members asked questions about the amendment and regulatory authority over local law enforcement agencies. 

Senator Pettersen distributed and explained Amendment L.199, which is a redraft of the overdose prevention review committee considered in a previously withdrawn amendment (Attachment P). 

Committee members asked questions about the review committee. 

Senato Gardner distributed and explained Amendment L.176, which makes possession of any amount of fentanyl a felony (Attachment Q). 

Senator Gardner distributed and explained Amendment  L.179, which makes changes to the mens rea and strikes "knowingly" possess (Atachment R). 

Mr. Baus answered questions about the amendment. 

Senator Gardner distributed and explained Amendment  L.180 which strikes the repeal date (Attachment S). 

Senator Gardner distributed and explained Amendment L.181  which requires prison time for any amount of fentanyl resulting in death (Attachment T). 

Senator Gardner distributed and explained Amendment L.194 that removes the Good Samaratan provision (Attachment U). 

The bill sponsors gave closing remarks.

Committee members explained their positions in support of, or in opposition to, the bill.